Amneal announced the launch of Diclofenac Sodium Topical Gel 1%, the generic version of Endo‘s Voltaren Gel.This marks the first-to-market generic product for Voltaren Gel. Diclofenac Sodium is ...

DUBLIN, May 21, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced its partner received final approval from the U.S. Food ...

The companies are introducing their diclofenac sodium topical gel 1% in 50-, 100- and 150-g laminate tubes after receiving Food and Drug Administration approval, and are partnering to bring the ...

As a result of today's announcement, Endo is revising its guidance for 2008. Net sales are now projected to be between $1.245 billion and $1.280 billion, up from the previous projections of $1.225 ...

DUBLIN, March 21, 2016 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) today provided a statement and a Frequently Asked Questions (FAQs) document regarding the expected approval by ...

QUESTION: My experience with Voltaren Gel was not good. At the time, my blood pressure was normally around 120/65. I take it most mornings now that I’m older and have some health issues.

Diclofenac (Voltaren Emul Gel (1% w/w)) is a non-steroidal anti-inflammatory drug (NSAID) prescribed to treat mild-to-moderate musculoskeletal pain. It helps to relieve: Tenderness, stiffness, and ...

* To provide more detail on potential financial impact of generic entrant for Voltaren gel no later than q1 2016 earnings presentation Source text for Eikon: Further company coverage: Sign up here ...

Annual market sales for Voltaren ® Gel, 1% for the 12 months ending March 2019 were approximately $350 million as measured by IQVIA™. Perrigo will manufacture diclofenac sodium topical gel 1% ...